What is a key reason for admitting a patient for benzodiazepine withdrawal treatment?

Study for the BIPC Substance Abuse and Disorders Exam. Challenge yourself with a variety of questions to enhance your knowledge and strengthen your preparation. Each question comes with hints and explanations to help you understand and retain crucial information.

Multiple Choice

What is a key reason for admitting a patient for benzodiazepine withdrawal treatment?

Explanation:
Admitting someone for benzodiazepine withdrawal treatment is about safety during the detox process. Stopping benzodiazepines can trigger rebound hyperexcitability that may lead to seizures and autonomic instability—things like rapid heart rate, high blood pressure, sweating, tremors, agitation, and even delirium. An inpatient setting provides continuous monitoring and access to a controlled taper, often using a long-acting benzodiazepine, so withdrawal symptoms are managed safely and seizures or other complications can be treated promptly. The goal is to prevent life-threatening events and ensure a smooth, supervised withdrawal. Choices focusing on weight monitoring or abrupt discontinuation don’t address these critical safety concerns, and using a short-acting benzodiazepine rapidly doesn’t reduce risk in withdrawal.

Admitting someone for benzodiazepine withdrawal treatment is about safety during the detox process. Stopping benzodiazepines can trigger rebound hyperexcitability that may lead to seizures and autonomic instability—things like rapid heart rate, high blood pressure, sweating, tremors, agitation, and even delirium. An inpatient setting provides continuous monitoring and access to a controlled taper, often using a long-acting benzodiazepine, so withdrawal symptoms are managed safely and seizures or other complications can be treated promptly. The goal is to prevent life-threatening events and ensure a smooth, supervised withdrawal. Choices focusing on weight monitoring or abrupt discontinuation don’t address these critical safety concerns, and using a short-acting benzodiazepine rapidly doesn’t reduce risk in withdrawal.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy